Highlights
High praise for MWC research from eminent scientists
Following a meeting in Auckland in February 2024, the Maurice Wilkins Centre Scientific Advisory Board, comprised of highly respected international scientists and science entrepren
read the full story
Population-specific genetic variants that alter responses to diabetes medication
A MWC programme of work around a SLC22A3 gene variant unique to Māori and Pacific peoples that could impact the way first line drug treatment is managed for people with type 2 diab
read the full story
Illuminating tumour micro environments
Advanced technical imaging capabilities and research projects supported by MWC are helping to identify new prognostic and diagnostic biomarkers to advance potential therapeutic tar
read the full story
“Immunity gap” revealed by changes in pathogen exposure during the pandemic
MWC researchers, in collaboration with the New Zealand Blood Service and CoRE Te Pūnaha Matatini, show reduced pathogen exposure altered New Zealanders’ immune status and susceptib
read the full story
MWC-China collaboration celebrates anti-cancer drug clinical trials
A longstanding relationship between MWC and Chinese researchers is celebrating its first clinical candidate undergoing Phase 1 trials. LX-132 targets many different types of cancer
read the full story
Awards recognise community reach of early career researchers
Six early career MWC-affiliated researchers are acknowledged through the MWC Early Career Steering Committee (ECSC) awards which recognise both scientific excellence and community
read the full story